Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy. [electronic resource]
Producer: 20100429Description: 1598-603 p. digitalISSN:- 1527-3792
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Aspirin -- therapeutic use
- Cyclooxygenase Inhibitors -- therapeutic use
- Disease Models, Animal
- Drug Screening Assays, Antitumor
- Female
- Gefitinib
- Naproxen -- therapeutic use
- Quinazolines -- therapeutic use
- Rats
- Rats, Inbred F344
- Research Design
- Resveratrol
- Stilbenes -- therapeutic use
- Urinary Bladder Neoplasms -- prevention & control
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.